ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cohen, E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cohen, E
Annals of Clinical and Laboratory Science, Vol 10, Issue 3, 258-262
Copyright © 1980 by Association of Clinical Scientists


Articles

Human lymphocyte receptors detected by invertebrate agglutinins

E Cohen

A review of recently published work is presented on the nature of the agglutination of human peripheral lymphocytes and cultured lymphoblastoid cells by the hemolymph agglutinins of two arachnoids, the Horsefoot (Limulus polyphemus), alias Horseshoe Crab, and the Saharan Scorpion (Androctonus australis). Microagglutination techniques were utilized to study the specificity of the whole serum and purified agglutinin(s) of Limulus and the whole serum agglutinin(s) of Androctonus. Peripheral human lymphocytes of patients with chronic lymphocytic leukemia (CLL) gave higher agglutination titers and scores than did normal cells, with both species of invertebrate agglutinins. However, human B cells gave higher, although overlapping degrees of agglutination, than T cells. The major cell membrane receptor site for agglutinins of both species was the sialic acid moiety, N-acetyl neuraminic acid. Selected literature on plant and invertebrate agglutinins (lectins) was reviewed. These lectins are underscored as valuable cell membrane probes of surface receptors of human lymphocyte subpopulations.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1980 by the Association of Clinical Scientists.